The Long-Term Benefits of Increased Aspirin Use by At-Risk Americans Aged 50 and Older

por Agus, David B., Gaudette, Étienne, Goldman, Dana P., Messali, Andrew
Publicado 2016

Health Care Resource Utilization Following Initiation of a Triptan: A Retrospective Claims Analysis

por Messali, Andrew, Owens, Gary, Bloudek, Lisa, Kori, Shashidhar, Cole, Ashley, Chia, Jenny
Publicado 2014

The Additional Costs per Month of Progression-Free Survival and Overall Survival: An Economic Model Comparing Everolimus with Cabozantinib, Nivolumab, and Axitinib for Second-Line...

por Swallow, Elyse, Messali, Andrew, Ghate, Sameer, McDonald, Evangeline, Duchesneau, Emilie, Perez, Jose Ricardo
Publicado 2018

Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole as First-Line Treatment for Invasive Aspergillosis

por Harrington, Rachel, Lee, Edward, Yang, Hongbo, Wei, Jin, Messali, Andrew, Azie, Nkechi, Wu, Eric Q., Spalding, James
Publicado 2016